Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)
Clinical trial NCT04903626 · COMPLETED
Trial details
- NCT number
- NCT04903626
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-24
- Primary completion
- 2024-09-17
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.